Analysis of age-specific adverse events with vancomycin: a real-world pharmacovigilance study based on the FAERS database

Real-world data from the large-scale FAERS database were used to detect vancomycin-associated adverse event signals by disproportionality analysis, Age-stratified comparisons revealed marked differences in adverse event signal. This pharmacovigilance research underscored potential safety concerns of vancomycin, corroborated known risks and identified novel safety signals not listed in the current product label. These findings expanded understanding of vancomycin's safety profile and provided evidence-based guidance for clinical practice.